1. Lubega J, Kim TO, Airewele G, Grimes A, et al.
   Risk factors and prognostic significance of platelet count abnormalities in children with HIV infection on anti-retrovirus therapy.
   AIDS 2022.
   


2. Jovanovic L, Siljic M, Cirkovic V, Salemovic D, et al.
   HIV-1 subtype B spread through cross-border clusters in the balkans: a molecular analysis in view of incidence trends.
   AIDS 2022.
   


3. Rasmussen LD, Cowan S, Gerstoft J, Kronborg G, et al.
   Outcomes following SARS-CoV-2 infection among individuals living with and without HIV; a Danish nationwide cohort study.
   AIDS 2022.
   


4. Ayton S, Schwitters A, Mantell JE, Nuwagaba-Biribonwoha H, et al.
   Male partner age, viral load, and HIV infection in adolescent girls and young women: Evidence from eight sub-Saharan African countries.
   AIDS 2022.
   


5. Youngpairoj AS, Vanderford TH, Reed MS, Granade TC, et al.
   A monoclonal antibody for the detection of the antiretroviral drug emtricitabine.
   AIDS 2022.
   


6. Keng LD, Winston A, Sabin CA.
   The global burden of cognitive impairment in people living with HIV: a systematic review and meta-analysis.
   AIDS 2022.
   


7. Myer L, Odayar J, Malaba TR, Allerton J, et al.
   Improved virologic outcomes in postpartum women living with HIV referred to differentiated models of care: a randomised controlled trial.
   AIDS 2022.
   


8. Sen S, An H, Oakes J, Eron J, et al.
   Effects of early human immunodeficiency virus infection on cerebral white matter blood flow autoregulation.
   AIDS 2022.
   


9. Stone J, Fraser H, Walker JG, Mafirakureva N, et al.
   Modelling the impact of HIV and HCV prevention and treatment interventions among people who inject drugs in Kenya.
   AIDS 2022.
   


10. Moran CA, Oliver NT, Szabo B, Collins LF, et al.
    The Association between Comorbidities and COVID-19 Hospitalization among People with HIV differs by Age.
    AIDS 2022.
    


11. Ruiz-Manriquez CA, Hernandez-Ruiz VA, Crabtree-Ramirez BE, Amieva H, et al.
    A lower CD4+/CD8+ ratio predicts activities of daily living decline among older adults with HIV.
    AIDS Res Hum Retroviruses 2022.
    


12. Hermans LE, Umunnakwe CN, Lalla-Edward ST, Hebel SK, et al.
    Point-Of-Care Tenofovir urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for HIV-1 Infection.
    Clin Infect Dis 2022.
    


13. Burns CM, Pung L, Witt D, Gao M, et al.
    Development of an HIV Risk Prediction Model Using Electronic Health Record Data from an Academic Health System in the Southern United States.
    Clin Infect Dis 2022.
    


14. Iqbal K, Dong X, Zhu W, Wiener J, et al.
    Decreased HIV diagnosis rates among Black and Hispanic or Latino MSM in U.S. jurisdictions supported by the THRIVE demonstration project, 2014-2019.
    Clin Infect Dis 2022.
    


15. Zanni MV, Foldyna B, McCallum S, Burdo TH, et al.
    Sex-Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation among People with HIV in the U.S.
    Clin Infect Dis 2022.
    


16. Elvstam O, Malmborn K, Elen S, Marrone G, et al.
    Virologic failure following low-level viremia and viral blips during antiretroviral therapy: results from a European multicenter cohort.
    Clin Infect Dis 2022.
    


17. Mave V, Chen L, Ranganathan UD, Kadam D, et al.
    Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India.
    Clin Infect Dis 2022.
    


18. Chammartin F, Darling K, Abela IA, Battegay M, et al.
    CD4:CD8 ratio and CD8 cell count and their prognostic relevance for coronary heart disease events and stroke in antiretroviral treated individuals: The Swiss HIV Cohort Study.
    J Acquir Immune Defic Syndr 2022.
    


19. Lemon TL, Tassiopoulos K, Tsai AC, Cantos K, et al.
    Health insurance coverage, clinical outcomes, and health-related quality of life among youth born to women living with HIV.
    J Acquir Immune Defic Syndr 2022.
    


20. Palella FJ, Hou Q, Li J, Mahnken J, et al.
    Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide.
    J Acquir Immune Defic Syndr 2022.
    


21. Moore DM, Nanfuka M, Zhang W, Okoboi S, et al.
    Limited impact of first-line drug resistance mutations on virologic response among patients receiving second-line anti-retroviral therapy in rural Uganda.
    J Acquir Immune Defic Syndr 2022.
    


22. Jacka BP, Nolen S, Bessey S, Zang X, et al.
    Use of pre-exposure prophylaxis (PrEP) to prevent rapid HIV transmission among people who inject drugs (PWID) in rural counties in the United States: A modeling study.
    J Acquir Immune Defic Syndr 2022.
    


23. Adebajo SB, Adebiyi R, Chama J, Bello S, et al.
    Depression and Sexual Stigma are Associated with Cardiometabolic Risk among Sexual and Gender Minorities Living with HIV in Nigeria.
    J Acquir Immune Defic Syndr 2022.
    


24. Bodley N, Dorward J, Naidoo J, Letsoalo M, et al.
    Diagnostic accuracy of the Alere Afinion AS100 point-of-care assay to screen for non-communicable diseases amongst people living with HIV.
    J Acquir Immune Defic Syndr 2022.
    


25. Faini D, Msafiri F, Munseri P, Bakari M, et al.
    The prevalence, incidence and risk factors for HIV among female sex workers - a cohort being prepared for a phase IIb HIV vaccine trial in Dar es Salaam, Tanzania.
    J Acquir Immune Defic Syndr 2022.
    


26. Bourgi K, Ofner S, Musick B, Griffith B, et al.
    Weight Gain among Treatment-naive Persons with HIV Receiving Dolutegravir in Kenya.
    J Acquir Immune Defic Syndr 2022.
    


27. Smith MSR, Mohan H, Ajaykumar A, Hsieh AYY, et al.
    Second-generation HIV integrase inhibitors induce differentiation dysregulation and exert toxic effects in human embryonic stem cell and mouse models.
    J Infect Dis 2022.
    


28. Serwin K, Scheibe K, Horecki M, Aksak-Was B, et al.
    Detection of Polish cases of highly virulent subtype B of HIV-1 originating in the Netherlands.
    J Med Virol 2022.
    


29. Luo R, Fong Y, Boeras D, Jani I, et al.
    The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
    Lancet 2022;400:887-895.
    


30. Technau KG, Mazanderani AH.
    Point-of-care HIV diagnosis for infants: the outcomes we need to achieve.
    Lancet 2022;400:864-865.
    


31. Collie S, Nayager J, Bamford L, Bekker LG, et al.
    Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.
    N Engl J Med 2022.
    


32. Duvenhage J, Draper HR, Garcia-Prats AJ, Winckler J, et al.
    Hepatocellular Injury in Children Treated for Rifampicin-resistant Tuberculosis: Incidence, Etiology and Outcome.
    Pediatr Infect Dis J 2022.
    


33. Desai N, Jenkins CA, Zanoni B, Nmoh A, et al.
    High Rates of Viral Suppression and Care Retention Among Youth Born Outside of the United States with Perinatally Acquired HIV.
    Pediatr Infect Dis J 2022.
    


34. Tegally H, San JE, Cotten M, Moir M, et al.
    The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance.
    Science 2022.
    


35. Hansen T, Baris J, Zhao M, Sutton RE, et al.
    Cell-based and cell-free firefly luciferase complementation assay to quantify Human Immunodeficiency Virus type 1 Rev-Rev interaction.
    Virology 2022;576:30-41.
    

Display articles in

• Abstract format
• Medline format